Oral Solid Dosage Pharmaceutical Market Overview
As per MRFR analysis, the Oral Solid Dosage Pharmaceutical Market Size was estimated at 213.48 (USD Billion) in 2022. The Oral Solid Dosage Pharmaceutical Market is expected to grow from 222.43 (USD Billion) in 2023 to 321.97 (USD Billion) by 2032. The Oral Solid Dosage Pharmaceutical Market CAGR (growth rate) is expected to be around 4.19% during the forecast period (2024 - 2032).
Key Oral Solid Dosage Pharmaceutical Market Trends Highlighted
The Global Oral Solid Dosage Pharmaceutical Market is driven by several key factors, including the increasing prevalence of chronic diseases, technological advancements, and government initiatives to improve healthcare access.
The market has witnessed growing demand for novel drug delivery systems, such as extended-release and targeted-release formulations, which offer enhanced patient compliance and efficacy.
Additionally, the rising adoption of personalized medicine and the development of innovative therapies for unmet medical needs are creating significant opportunities for market players.
Recent trends in the Oral Solid Dosage Pharmaceutical Market include a focus on sustainability and environmental consciousness.
Manufacturers are investing in eco-friendly packaging and manufacturing processes to reduce their carbon footprint.
Furthermore, the advent of digital health technologies, such as smart pill dispensers and patient monitoring apps, is transforming the delivery and monitoring of oral solid dosage medications. These advancements enhance patient adherence, improve medication safety, and facilitate real-time data collection for personalized treatment plans.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Oral Solid Dosage Pharmaceutical Market Drivers
Rising Prevalence of Chronic Diseases
Chronic diseases such as cardiovascular diseases, diabetes, and cancer are the increasing prevalence key drivers of the Global Oral Solid Dosage Pharmaceutical Market. The diseases need long-term treatment, and most of the time, the best form of formulation to be used is oral solid dosage.
The growth of the oral solid dosage pharmaceuticals market is dependent on the increase of the people with chronic diseases. According to the World Health Organization, chronic diseases are the leading cause of death across the world, which accounts for over 70% of all deaths across the globe.
The increase in such diseases is attributed to the increase in physical inactivity, aging populations, unhealthy diets, and tobacco. As a result, the demand for oral solid dosage pharmaceutical products is expected to increase due to the increase in chronic diseases.
Technological Advancements
Technological advancements in the pharmaceutical industry are also contributing to the growth of the Global Oral Solid Dosage Pharmaceutical Market. These advancements include the development of new drug delivery systems, such as controlled-release formulations and targeted drug delivery systems.
These systems can improve the efficacy and safety of oral solid dosage forms, making them more attractive to patients and healthcare providers. For example, controlled-release formulations can provide sustained release of the drug over time, reducing the need for frequent dosing.
Targeted drug delivery systems can deliver the drug directly to the site of action, minimizing side effects. As technological advancements continue to improve the efficacy and safety of oral solid dosage forms, the demand for these products is expected to increase.
Increased Demand for Patient-Centric Healthcare
The increasing demand for patient-centric healthcare is also driving the growth of the Global Oral Solid Dosage Pharmaceutical Market. Patients are becoming more involved in their own healthcare decisions, and they are increasingly seeking out treatments that are convenient and easy to use.
Oral solid dosage forms are often preferred by patients because they are easy to take and can be administered at home. In addition, oral solid dosage forms are often less expensive than other dosage forms, such as injectables or infusions.
As the demand for patient-centric healthcare continues to grow, the demand for oral solid dosage pharmaceuticals is expected to increase accordingly.
Oral Solid Dosage Pharmaceutical Market Segment Insights:
Oral Solid Dosage Pharmaceutical Market Product Type Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented by product type into tablets, capsules, powders, granules, lozenges, and others. Tablets held the largest market share in 2023, accounting for over 50% of the global market.
Capsules are expected to witness the fastest growth during the forecast period, owing to their ease of administration and improved bioavailability. Tablets are solid dosage forms that contain active pharmaceutical ingredients (APIs) and excipients. They are manufactured by compressing the APIs and excipients into a solid form.
Tablets offer several advantages, such as accurate dosing, ease of administration, and stability. They are also relatively inexpensive to manufacture. Capsules are another type of solid dosage form that consists of a shell made of gelatin or other materials that enclose the APIs.
Capsules are typically filled with powders, granules, or liquids. They offer several advantages, such as improved bioavailability, reduced gastrointestinal irritation, and ease of administration. Powders are solid dosage forms that consist of fine particles of APIs and excipients.
They are typically administered orally by suspending them in a liquid or by sprinkling them on food. Powders offer several advantages, such as rapid absorption, ease of administration, and flexibility in dosing. Granules are solid dosage forms that consist of small, spherical particles of APIs and excipients.
They are typically administered orally by suspending them in a liquid or by sprinkling them on food. Granules offer several advantages, such as improved flowability, reduced dustiness, and ease of administration. Lozenges are solid dosage forms that are designed to dissolve slowly in the mouth.
They typically contain APIs and excipients that provide a soothing effect on the throat and mouth. Lozenges are often used to treat sore throats, coughs, and other minor ailments. Other solid dosage forms include suppositories, implants, and transdermal patches.
The growth of the market is attributed to the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and the growing adoption of advanced drug delivery technologies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Oral Solid Dosage Pharmaceutical Market Application Insights
The application segments of the Oral Solid Dosage Pharmaceutical Market include Cardiovascular, Anti-infectives, Central Nervous System, Pain Management, Anti-inflammatory, and Others. The Cardiovascular segment held the largest market share in 2023 at 32.7% and is expected to maintain its dominant position throughout the forecast period.
The increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and stroke, is driving the growth of the segment. Another noteworthy segment is Anti-infectives, which comprised 24.5% of the Oral Solid Dosage Pharmaceutical Market revenue in 2023.
The rising incidence of infectious diseases, along with the growing demand for antibiotics and antivirals, is expected to drive the segment expansion. The Central Nervous System segment is another notable segment that is growing steadily.
The surging prevalence of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and MS, is expected to drive demand for orally administered medications. Pain Management and Anti-inflammatory segments are also noteworthy, both providing a large market share.
The rising prevalence of chronic pain conditions, including arthritis, back pain, and headaches, is driving demand for Pain Management.
Inflammatory conditions, such as asthma, COPD, and Crohn disease are increasing in incidence, driving the Anti-inflammatory segment. Others, including various other applications, such as oncology, endocrinology, and respiratory, are expected to grow at a slow rate throughout the forecast period.
In general, the prevalence of major chronic diseases is surging and creating demand for orally administered pharmaceuticals to treat the conditions.
Oral Solid Dosage Pharmaceutical Market Manufacturing Route Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented into various manufacturing routes, including Direct Compression, Granulation, Extrusion-Spheronization, Coating, and Film Coating. Each route offers distinct advantages and is suitable for specific types of formulations.
Direct Compression involves directly compressing powdered ingredients into tablets, making it a simple and cost-effective method. In 2023, the Direct Compression segment accounted for approximately 32.5% of the Global Oral Solid Dosage Pharmaceutical Market revenue.
Granulation involves moistening and agglomerating powdered ingredients to form granules, which are then compressed into tablets. This method is commonly used for formulations that require high drug loading or sustained release.
The Granulation segment held a market share of around 27.4% in 2023. Extrusion-Spheronization involves extruding a wet mass through a perforated plate to form cylindrical strands, which are then spheronized to create round beads. This method is suitable for formulations requiring precise drug distribution and sustained release.
The Extrusion-Spheronization segment accounted for approximately 19.1% of the market revenue in 2023. Coating involves applying a thin layer of material onto the surface of tablets or granules to protect them from moisture, improve taste, or control drug release.
The Coating segment held a market share of around 13.8% in 2023. Film Coating is a specialized type of coating that involves applying a thin, continuous film onto the surface of tablets or granules. This method provides excellent protection against moisture and environmental factors. The Film Coating segment accounted for approximately 7.2% of the market revenue in 2023.
The choice of manufacturing route depends on factors such as formulation properties, desired release profile, and cost considerations. The increasing demand for complex formulations and the need for improved drug delivery systems are driving the growth of the Oral Solid Dosage Pharmaceutical Market, with various manufacturing routes catering to specific formulation requirements.
Oral Solid Dosage Pharmaceutical Market Form Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented by Form into Immediate Release, Sustained Release, Extended Release, Controlled Release, and Enteric Coated. Among these, the Immediate Release segment held the largest market share in 2023, accounting for over 40% of the global market revenue.
This is due to the ease of manufacturing, low cost, and wider acceptance of immediate-release dosage forms. However, the Sustained Release segment is expected to register the highest CAGR during the forecast period, owing to the increasing demand for drugs that can be administered less frequently and provide a more consistent therapeutic effect.
For instance, in 2023, the market size of the Sustained Release segment is estimated to be around USD 65 billion and is projected to reach USD 95 billion by 2032, exhibiting a CAGR of 4.5%.
The growth of this segment can be attributed to the increasing prevalence of chronic diseases, such as cardiovascular diseases and diabetes, which require long-term medication.
Oral Solid Dosage Pharmaceutical Market Dosage Strength Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented by Dosage Strength into Low, Medium, High, Ultra-High, and Specialty. Among these, the Low Dosage Strength segment held the largest market share in 2023, accounting for around 42.1% of the global market revenue.
This dominance is attributed to the high prevalence of chronic diseases requiring low-dose medications, such as hypertension and diabetes.
The Medium Dosage Strength segment is anticipated to exhibit the fastest growth during the forecast period 2024-2032, owing to the increasing adoption of personalized medicine and targeted drug delivery systems.
Specialty Dosage Strength, which includes controlled-release and extended-release formulations, is expected to gain significant market share due to its ability to enhance patient compliance and improve therapeutic outcomes.
Oral Solid Dosage Pharmaceutical Market Route of Administration Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented based on the Route of Administration into Oral, Sublingual, Buccal, Nasal, and others. Among these segments, the Oral segment holds the largest market share due to the ease of administration and patient convenience.
The Sublingual and Buccal segments are expected to witness significant growth in the coming years due to the rising prevalence of chronic diseases such as diabetes and cardiovascular disorders. The Nasal segment is also expected to grow at a steady pace due to its non-invasive nature and the increasing adoption of nasal sprays for respiratory conditions.
Oral Solid Dosage Pharmaceutical Market Target Patient Population Insights
The Global Oral Solid Dosage Pharmaceutical Market segmentation by Target Patient Population includes Adults, Geriatrics, Pediatrics, Neonates, and Pregnant Women. The adult segment accounted for the largest share of the market in 2023 and is expected to continue to dominate the market throughout the forecast period.
This growth is attributed to the increasing prevalence of chronic diseases among adults, such as cardiovascular diseases, diabetes, and cancer. The geriatric segment is also expected to witness significant growth over the forecast period due to the rising geriatric population worldwide.
The increasing incidence of age-related diseases, such as dementia and Alzheimer's disease, is driving the demand for oral solid dosage pharmaceuticals in this segment.
The pediatric segment is expected to have a moderate growth rate during the forecast period, driven by the increasing prevalence of childhood diseases, such as asthma, allergies, and ADHD.
The neonate segment is expected to have a slow growth rate, while the pregnant women segment is expected to have a moderate growth rate.
Oral Solid Dosage Pharmaceutical Market Regional Insights
The Global Oral Solid Dosage Pharmaceutical Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America dominates the market with a revenue of USD 102.3 billion in 2023 and is projected to reach USD 147.2 billion by 2032, growing at a CAGR of 4.2%.
This growth is attributed to the increasing prevalence of chronic diseases, rising demand for generic drugs, and technological advancements in drug delivery systems. Europe is the second-largest market, followed by APAC, South America, and MEA.
The APAC region is expected to witness significant growth in the coming years due to the increasing population, rising healthcare expenditure, and growing awareness about the importance of oral solid dosage forms.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Oral Solid Dosage Pharmaceutical Market Key Players and Competitive Insights:
Major players in the Oral Solid Dosage Pharmaceutical Market are constantly striving to gain a competitive edge by investing in research and development (R&D) to create innovative products that meet unmet medical needs.
These companies are also focusing on expanding their global presence through strategic partnerships, acquisitions, and joint ventures. The Oral Solid Dosage Pharmaceutical Market is highly fragmented, with many small and medium-sized players competing for market share.
However, the leading Oral Solid Dosage Pharmaceutical Market players account for a significant portion of the market revenue. These leading players have established strong brand recognition, extensive distribution networks, and a robust product portfolio that caters to a wide range of therapeutic areas.
Pfizer Inc. is a leading player in the Oral Solid Dosage Pharmaceutical Market. The company has a strong presence in various therapeutic areas, including cardiovascular, oncology, and immunology. Pfizer's commitment to innovation has resulted in the development of several blockbuster drugs, such as Lipitor, Viagra, and Lyrica.
The company has a global reach and operates in over 150 countries. Pfizer's strong financial position allows it to invest heavily in R&D and marketing, which has contributed to its success in the Oral Solid Dosage Pharmaceutical Market.
Merck & Co., Inc. is another major player in the Oral Solid Dosage Pharmaceutical Market. The company has a diverse product portfolio that includes drugs for cardiovascular diseases, diabetes, and cancer. Merck's focus on R&D has led to the development of innovative products, such as Keytruda, Januvia, and Gardasil.
The company has a strong global presence and operates in over 140 countries. Merck's commitment to patient care and its strong financial position makes it a formidable competitor in the Oral Solid Dosage Pharmaceutical Market.
Key Companies in the Oral Solid Dosage Pharmaceutical Market Include:
- Pfizer
- Roche Holding
- Johnson Johnson
- Sanofi
- Eli Lilly and Company
- Novartis
- Abbott Laboratories
- AstraZeneca
- Bristol-Myers Squibb
- Teva Pharmaceutical Industries
- GlaxoSmithKline
- AbbVie
- Mylan
- Bayer
- Merck Co
Oral Solid Dosage Pharmaceutical Market Developments
The market growth is attributed to the rising prevalence of chronic diseases, increasing demand for patient-centric drug delivery systems, and technological advancements in manufacturing processes. The growing geriatric population, coupled with the launch of new products, is further expected to drive market expansion.
Key industry participants are focusing on strategic collaborations and acquisitions to strengthen their market position and expand their product portfolio.
Recent news developments include the acquisition of AMRI by Alcami, strengthening Alcami's position in the CDMO market.
Additionally, the FDA's approval of new oral solid dosage drugs, such as Xywav, for treating excessive daytime sleepiness in adults with narcolepsy is expected to contribute to market growth.
Oral Solid Dosage Pharmaceutical Market Segmentation
Oral Solid Dosage Pharmaceutical Market Product Type Outlook
- Tablets
- Capsules
- Powders
- Granules
- Lozenges
- Others
Oral Solid Dosage Pharmaceutical Market Application Outlook
- Cardiovascular
- Anti-infectives
- Central Nervous System
- Pain Management
- Anti-inflammatory
- Others
Oral Solid Dosage Pharmaceutical Market Manufacturing Route Outlook
- Direct Compression
- Granulation
- Extrusion-Spheronization
- Coating
- Film Coating
Oral Solid Dosage Pharmaceutical Market Form Outlook
- Immediate Release
- Sustained Release
- Extended Release
- Controlled Release
- Enteric Coated
Oral Solid Dosage Pharmaceutical Market Dosage Strength Outlook
- Low
- Medium
- High
- Ultra-High
- Specialty
Oral Solid Dosage Pharmaceutical Market Route of Administration Outlook
- Oral
- Sublingual
- Buccal
- Nasal
Oral Solid Dosage Pharmaceutical Market Target Patient Population Outlook
- Adults
- Geriatrics
- Pediatrics
- Neonates
- Pregnant Women
Oral Solid Dosage Pharmaceutical Market Regional Outlook
- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
 213.48 (USD Billion) |
| Market Size 2023 |
 222.43 (USD Billion) |
| Market Size 2032 |
 321.97 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
4.19% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Pfizer, Roche Holding, Johnson Johnson, Sanofi, AbbVie, Eli Lilly and Company, Novartis, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical Industries, GlaxoSmithKline, Mylan, Bayer, Merck Co |
| Segments Covered |
Product Type, Application, Manufacturing Route, Form, Dosage Strength, Route of Administration, Target Patient Population, Regional |
| Key Market Opportunities |
1 Emerging markets expansion 2 Technological advancements 3 Growing prevalence of chronic diseases 4 Increasing demands for customized dosage forms 5 Rise of personalized medicine |
| Key Market Dynamics |
Technological advancements in drug delivery systems Rising prevalence of chronic diseases Increasing geriatric population Government initiatives to expand access to healthcare Growth in emerging markets |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Global Oral Solid Dosage Pharmaceutical Market is expected to reach a valuation of USD 222.43 billion by 2023 and is projected to register a CAGR of 4.19% to reach USD 321.97 billion by 2032.
The growth of the Global Oral Solid Dosage Pharmaceutical Market is attributed to factors such as the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and the growing adoption of advanced drug delivery technologies.
North America is expected to hold the largest market share in the Global Oral Solid Dosage Pharmaceutical Market, followed by Europe and Asia-Pacific.
Oral Solid Dosage Pharmaceuticals are primarily used for the treatment of a wide range of diseases, including cardiovascular diseases, diabetes, respiratory diseases, and gastrointestinal disorders.
Some of the key competitors in the Global Oral Solid Dosage Pharmaceutical Market include Pfizer, Novartis, Merck Co., GlaxoSmithKline, and Sanofi.
The Global Oral Solid Dosage Pharmaceutical Market faces challenges such as the increasing cost of drug development, the stringent regulatory environment, and the growing competition from generic and biosimilar drugs.
The Global Oral Solid Dosage Pharmaceutical Market presents opportunities for growth in areas such as the development of new and innovative drug formulations, the expansion into emerging markets, and the adoption of digital health technologies.
Key trends shaping the Global Oral Solid Dosage Pharmaceutical Market include the increasing focus on patient-centricity, the growing adoption of personalized medicine, and the emergence of new technologies such as 3D printing.
The COVID-19 pandemic has had a significant impact on the Global Oral Solid Dosage Pharmaceutical Market, leading to disruptions in supply chains, clinical trials, and manufacturing operations.
Oral Solid Dosage Pharmaceuticals are subject to stringent regulatory requirements to ensure their safety and efficacy, which vary across different countries and regions.
